Latest Breaking News On - Called casgevy - Page 1 : comparemela.com

The first therapy based on gene editing technology Crispr-Cas9 for sickle cell disease and thalassaemia has been approved in UK. The potential for India is revolutionary however, cost is a huge deterrent currently

Debojyoti chakrabortyUnion budgetInstitute of genomicsCalled casgevySickle cellIntegrative biologySickle cell therapyIckle cell disease and thalassaemiaExplained healthNdian express explainedExplained newsXplained articles